1. Home
  2. Author
  3. Harouki N

Harouki N

References (2)

Title : Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice - Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
Author(s) : Roche C , Besnier M , Cassel R , Harouki N , Coquerel D , Guerrot D , Nicol L , Loizon E , Remy-Jouet I , Morisseau C , Mulder P , Ouvrard-Pascaud A , Madec AM , Richard V , Bellien J
Ref : American Journal of Physiology Heart Circ Physiol , 308 :H1020 , 2015
Abstract : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
ESTHER : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
PubMedSearch : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020
PubMedID: 25724490

Title : Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice - Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
Author(s) : Roche C , Guerrot D , Harouki N , Duflot T , Besnier M , Remy-Jouet I , Renet S , Dumesnil A , Lejeune A , Morisseau C , Richard V , Bellien J
Ref : Prostaglandins Other Lipid Mediat , 120 :148 , 2015
Abstract : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
ESTHER : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
PubMedSearch : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148
PubMedID: 26022136